Humic acid suppresses the LPS-induced expression of cell- surface adhesion proteins through the inhibition of NF-κB activation

Toxicology and Applied Pharmacology

Volumn 166, Issue 1, 2000, Pages 59-67

  Gau, Rung Jiun ^a   Yang, Hsin Ling ^b   Chow, Song Nan ^a   Suen, Jau Ling ^a   Lu, Fung Jou ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adhesion molecules; Blackfoot disease; Endothelial cells; Humic acid; Nuclear factor kappa B

Indexed keywords

CELL ADHESION MOLECULE; CELL DNA; DRINKING WATER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTOXIN; HUMIC ACID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLACKFOOT DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; UMBILICAL VEIN;

MELAMPODIUM;

EID: 0034234285     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2000.8954     Document Type: Article

References (47)

1. Aiken N. R., Thurman E. M., Maleolm G. L. Comparison of XAD macroporous resins for the concentration of fulvic acid from aqueous solution. Anal. Chem. 51:1979;1799-1803.
2. Baeuerle P. A., Baichwal V. R. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 65:1997;111-137.
3. Barchowsky A., Dudek E. J., Treadwell M. D., Wetterhahn K. E. Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radical Biol. Med. 21:1996;783-790.
4. Burges N. A., Hurst H. M., Walkane B. The phenolic constituents of humic acid and their relationship to the lignin of the plant cover. Geochim. Cosmochim. Acta. 28:1964;1547-1554.
5. Carmichael J., DeGraff W. G., Grazdar A. F., Minna J. D., Mitchell J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity test. Cancer Res. 47:1987;936-942.
6. Chen C. J., Wu M. M., Lee S. S., Wang J. D., Cheng S. H., Wu H. Y. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 8:1988;452-460.
7. 3) on cultured human umbilical vein endothelial cells. J. Dermatol. 17:1990;599-608.
8. Chen K. P., Wu H. Y. Epidemiologic studies on blackfoot: 2. Study of source of drinking water in relation to the disease. J. Formosan Med. Assoc. 61:1962;611-618.
9. Chen K. P., Wu H. Y. Epidemiologic studies on blackfoot disease in Taiwan, China. 6. Effect of the piped water supply on occurrence and disease progress of blackfoot disease. J. Formosan Med. Assoc. 68:1969;291-295.
10. Cheng M. L., Ho H. Y., Chiu T. Y., Lu F. J. Humic acid-mediated oxidative damage to human erythrocytes: A possible mechanism leading to anemia in blackfoot disease. Free Radical Biol. Med. 27:1999;470-477.
11. Chiu H. C., Shih S. R., Lu F. J., Yang H. L. Stimulation of endothelin production in cultured human endothelial cells by fluorescent compounds associated with blackfoot disease. Thromb. Res. 69:1993;139-151.
12. Choundhry G. G. Humic substance. I. Structural aspects. Toxicol. Environ. Chem. 4:1981;209-259.
13. Collins T., Read M. A., Neish A. S., Whitley M. Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
14. Furutani Y. Molecular studies on interleukin-1a. Eur. Cytokine Netw. 5:1994;533-538.
15. Furutani Y., Notake M., Fukui T., Ohue M., Nomura H., Yamada M., Nakamura S. Complete nucleotide sequence of the gene for human interleukin 1 alpha. Nucleic Acid Res. 14:1986;3167-3179.
16. Gonzalez-Amaro R., Diaz-Gonzalez F., Sanchez-Madrid F. Adhesion molecules in inflammatory diseases. Drugs. 56:1998;977-988.
17. Hanninen K. I., Klocking R., Helbig B. Synthesis and characterization of humic acid-like polymers. Sci. Total Environ. 62:1987;201-210.
18. Hartenstein R. Sludge decomposition and stabilization. Science. 212:1981;743-749.
19. Huang T. S., Lu F. J., Tsai C. W., Chopra I. J. Effect of humic acids on thyroidal function. J. Endocrinol. Invest. 17:1994;787-791.
20. Huang T. S., Lu F. J., Tsai C. W. Tissue distribution of absorbed humic acids. Environ. Geochem. Health. 17:1995;1-4.
21. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical vein. J. Clin. Invest. 52:1973;2745-2756.
22. Keyser P., Pujar B. J., Eaton R. W., Ribon D. W. Biodegradation of the phthalates and their esters by bacteria. Environ. Health Perspect. 18:1976;159-166.
23. Klemperer N. S., Pickart C. M. Arsenite inhibits two steps in the ubiquitin-dependent proteolytic pathway. J. Biol. Chem. 264:1989;19245-19252.
24. Liou H. C., Baltimore D. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell Biol. 5:1993;477-487.
25. Lu F. J., Yang C. K., Lin K. H. Physico-chemical characteristics of drinking water in blackfoot disease endemic areas in Chia-I and Tainan Hsiens. J. Formosan Med. Assoc. 74:1975;596-605.
26. Lu F. J., Liu T. M. Fluorescent compounds in drinking water of blackfoot disease endemic areas: Animal experimental model. J. Formosan Med. Assoc. 85:1986;352-358.
27. Lu F. J., Yamamura Y., Yamauchi H. Studies on fluorescent compounds in water of a well in blackfoot disease endemic areas in Taiwan: Humic substances. J. Formosan Med. Assoc. 87:1988;66-75.
28. Lu F. J. Blackfoot disease: Arsenic or humic acid? Lancet. 336:1990a;115-116.
29. Lu F. J. Fluorescent humic substances and blackfoot disease in Taiwan. Appl. Organomet. Chem. 4:1990b;191-195.
30. Lu F.J., Huang T.S., Lin Y.S., Pang V.F., Lin S.Y. Peripheral vasculopathy in rats induced by humic acids. Appl. Organometallic Chem. 8:1994;223-228.
31. Murase T., Kume N., Hase T., Shibuya Y., Nishizawa Y., Tokimitsu I., Kita T. Gallates inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of leukocyte adhesion molecules in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19:1999;1412-1420.
32. Schreiber E., Matthias P., Muller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
33. Shumilla J. A., Wetterhahn K. E., Barchowsky A. Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: Evidence of a thiol mechanism. Arch. Biochem. Biophys. 349:1998;356-362.
34. Trede N. S., Tsytsykova A. V., Chatila T., Goldfeld A. E., Geha R. S. Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: Role of NF-kappa B. J. Immunol. 155:1995;902-908.
35. Tseng W. P., Chen W. Y., Sung J. L. A clinical study of blackfoot disease in Taiwan, an endemic peripheral vascular disease. Mem. Coll. Med. Natl. Taiwan Univ. 7:1961;1-18.
36. Tseng W. P. Effects and dose response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19:1977;109-119.
37. Xie Q. W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
38. Yang H. L., Lu F. J., Wung S. L., Chiu H. C. Humic acid induces expression of tissue factor by cultured endothelial cells: Regulation by cytosolic calcium and protein kinase C. Thromb. Haemostasis. 71:1994a;325-330.
39. Yang H. L., Tu S. C., Lu F. J., Chiu H. C. Plasma protein C activity is enhanced by arsenic but inhibited by fluorescent humic acid associated with blackfoot disease. Am. J. Hematol. 46:1994b;264-269.
40. Yang H. L., Chiu H. C., Lu F. J. Effects of humic acid on the viability and coagulant properties of human umbilical vein endothelial cells. Am. J. Hematol. 51:1996;200-206.
41. Yang H. L., Hseu Y. C., Lu F. J., Tsai H. D. Humic acid reduces protein-C-activating cofactor activity of thrombomodulin of human umbilical vein endothelial cells. Br. J. Haematol. 101:1998;16-23.
42. Yeh S., How S. W. A pathological study on the blackfoot disease in Taiwan. Rep. Inst. Pathol Natl. Taiwan Univ. 14:1963;25-73.
43. Young H. A. Regulation of interferon-gamma gene expression. J. Interferon Cytokine Res. 16:1996;569-576.
44. Yu H. S. Blackfoot disease and chronic arsenism in southern Taiwan. Int. J. Dermatol. 23:1984;258-260.
45. Yu H. S., Sheu H. M., Ko S. S., Chiang L. C., Chien C. H., Lin S. M., Tserng B. R., Chen C. S. Studies on blackfoot disease and chronic arsenism in southern Taiwan: With special reference to skin lesions and fluorescent substances. J. Dermatol. 11:1984;361-370.
46. Yu, H. S, Chang, K. L, Chen, G. S, and, Kao, Y. C. 1992, Report on Blackfoot Research. Study of Immunological Function in Patients with Blackfoot Disease and Effect of Fluorescent Substance and Arsenic on Immune System. No. 39, Taiwan Provincial Department of Health, Taichung.
47. Yu H. S., Chang K. L., Kao Y. H., Yu C. L., Chen G. S., Chang C. H., Fang K. T. In vitro cytotoxicity of IgG antibodies on vascular endothelial cells from patients with endemic peripheral vascular disease in Taiwan. Atherosclerosis. 137:1998;141-147.